News from the healthcare data industry
Newswise — McLean, Va., March 7, 2022— MITRE named Dr. Stephen Ondra as the new Chief Medical Advisor for MITRE’s work as operator of the CMS Alliance to Modernize Healthcare federally funded research and development center (Health FFRDC). The Health FFRDC is sponsored by the Centers for Medicare & Medicaid Services (CMS) and available…
Tyra Biosciences supported study investigates if non-invasive blood and urine samples provide biomarkers to assess clinical response to erdafitinib treatment OAKLAND, CALIFORNIA, UNITED STATES, March 10, 2022 /EINPresswire.com/ — Today, xCures announced their collaboration with Tyra Biosciences for a real-world biomarker study involving patients with FGFR-mutant bladder cancer receiving Balversa® (erdafitinib)…
TUCSON, Ariz., March 10, 2022 — Critical Path Institute (C-Path) and Tufts Medical Center have announced a collaboration to transfer electronic healthcare records (EHR) data to C-Path as part of the real-world data (RWD) effort to generate actionable real-world evidence (RWE) for neonatal drug development. This initiative, funded by a grant from the U.S….
Matthew W. Reynolds, Vice President, Real World Solutions, IQVIA 03.09.22Recent FDA guidance on using real world data (RWD) to study the safety and effectiveness of products and treatments represents an exciting advancement for clinical research. Opportunities for RWD usage have existed for many years now and has grown more rapidly during the pandemic,…
March 09, 2022 04:15 PM Eastern Standard Time WASHINGTON–(BUSINESS WIRE)–Today, the RWE Alliance submitted a substantial comment letter in response to the U.S. Food and Drug Administration’s (FDA) recent draft guidance, “Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products.”…
February 26, 2022—Phoenix, Arizona—Use of benralizumab in patients aged 12 and over with severe eosinophilic asthma results in significant reduction in asthma exacerbations, oral corticosteroid use, and healthcare resources utilization, according to a real-world analysis presented at the American Academy of Allergy, Asthma, & Immunology Annual Meeting, which took place…
Report Prepared by the Oncology Industry Taskforce RWE Working Group, a Medicines Australia Initiative Read the Report here: https://www.medicinesaustralia.com.au/wp-content/uploads/sites/65/2020/11/OIT-RWE-Report-Oct-2020-FINAL-MA-VERSION.pdf
Background: Abiraterone and enzalutamide are widely used as first-line treatment for metastatic castration-resistant prostate cancer (mCRPC); however, their efficacy in mCRPC has been inconsistently demonstrated in other outcome studies from real-world databases. The aim of our study was to assess the comparative effectiveness of abiraterone and enzalutamide in patients with mCRPC…
MIAMI—Google Health is expanding the capabilities of its clinician-facing search tool using artificial intelligence to bring context to physicians’ clinical notes. Speaking at the ViVE 2022 conference, Paul Muret, vice president and general manager of Care Studio at Google Health, announced new features of the company’s clinical software that harmonizes healthcare data from…
Newswise — Lawrenceville, NJ, USA—March 8, 2022—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) in partnership with the Bristol Myers Squibb-Pfizer Alliance announced that it has launched a new “About Real-World Evidence” microsite. This introductory content is designed for the broader healthcare audience toward the goal of engaging…